
Allelica, a precision medicine company focused on genomic risk assessment for common diseases, today announced that it has entered into a commercial license agreement with Cambridge Enterprise, the innovation office of the University of Cambridge

Allelica, the global leader in clinical polygenic risk score (PRS) testing, today announced the launch of AbsoluteDx, a comprehensive, clinical genetic test that combines monogenic and polygenic risk assessment in a single, streamlined solution

Last week at the American Society of Human Genetics (ASHG) Annual Meeting, the leaders in clinical polygenic risk score (PRS) analysis at Allelica unveiled a groundbreaking approach to modeling human genetic diversity without predefined labels

Allelica, Inc., a leading provider of software tools for polygenic risk scores (PRS), announced a collaboration with Thermo Fisher Scientific, the world leader in serving science, to utilize Allelica's bioinformatics software with Thermo Fisher's Axiom™

Allelica, market leader in clinical solutions for polygenic risk score analysis and reporting, has announced a strategic collaboration with leading health sciences institution, Baylor College of Medicine (BCM), to integrate clinical, multi-ancestry polygen

Allelica announces the release of the Allelica Precision Server for CLIA-compliant, on-premises analysis and clinical reporting of polygenic risk score, pharmacogenomics and carrier screening

UAB Cardiogenomics Clinic and Allelica to perform polygenic risk score clinical implementation study

Allelica Launches Ancestry-Specific Polygenic Risk Score Tests for Common Diseases as a Laboratory-Developed Test

Allelica's Health Economics Study Demonstrates Cost Savings of Polygenic Risk Score in Heart Attack Prevention

Allelica Collaborates with Invitae to Build Ancestry-Informed Polygenic Risk Score for Breast Cancer

Allelica Joins Forces with Leader in Genotyping Technology to Enable Polygenic Risk Score

Yale School of Medicine Researcher Selects Allelica to Expand Polygenic Risk Score Research on Childhood Neuropsychiatric Disorders